Insomnia Drugs Market Size, Share & Industry Analysis, By Drug Class (Dual Orexin Receptor Antagonists (DORAs), Z-drugs/Non-Benzodiazepine Hypnotics, Benzodiazepine Hypnotics, Melatonin Pathway Agents, and Others), By Disease Indication (Primary Chronic Insomnia Disorder, Comorbid Psychiatric Insomnia, Comorbid Neurologic/Pain-Related Insomnia, & Others), By Age Group (Adults and Pediatric), By Type (Branded and Generic), By Route of Administration (Oral and Others), By Distribution Channel (Hospital pharmacies, Drug Stores & Retail Pharmacies, & Others), and Regional Forecast, 2026-2034